Landscapes / Companies
Lee's Pharmaceutical Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials · 15 in all
Trials
4 active
23 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Approved in China | 1 Sep 2027Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 1 Sep 2027 · Phase 3 trial completes | ||||
| Also tested for | Cervical Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2027Phase 3 trial completes | |||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | 5-aminolevulinic Acid, Fluorescence-guided Resection and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Cancer | ||||
| Open drug page | |||||
About
- No active trial
- 11 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021